rs11888095

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001378107.1(R3HDM1):​c.2152+3821C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 152,136 control chromosomes in the GnomAD database, including 2,818 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2818 hom., cov: 32)

Consequence

R3HDM1
NM_001378107.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.527

Publications

15 publications found
Variant links:
Genes affected
R3HDM1 (HGNC:9757): (R3H domain containing 1) Enables RNA binding activity. [provided by Alliance of Genome Resources, Apr 2022]
MIR128-1 (HGNC:31510): (microRNA 128-1) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.306 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378107.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
R3HDM1
NM_001378107.1
MANE Select
c.2152+3821C>T
intron
N/ANP_001365036.1
R3HDM1
NM_001282798.2
c.2050+3821C>T
intron
N/ANP_001269727.1
R3HDM1
NM_001354200.2
c.2050+3821C>T
intron
N/ANP_001341129.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
R3HDM1
ENST00000683871.1
MANE Select
c.2152+3821C>T
intron
N/AENSP00000506980.1
R3HDM1
ENST00000264160.8
TSL:1
c.2047+3821C>T
intron
N/AENSP00000264160.4
R3HDM1
ENST00000409478.5
TSL:1
c.1663+3821C>T
intron
N/AENSP00000386457.1

Frequencies

GnomAD3 genomes
AF:
0.167
AC:
25364
AN:
152018
Hom.:
2816
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.289
Gnomad AMI
AF:
0.0725
Gnomad AMR
AF:
0.212
Gnomad ASJ
AF:
0.109
Gnomad EAS
AF:
0.167
Gnomad SAS
AF:
0.321
Gnomad FIN
AF:
0.110
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.0839
Gnomad OTH
AF:
0.168
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.167
AC:
25391
AN:
152136
Hom.:
2818
Cov.:
32
AF XY:
0.171
AC XY:
12720
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.289
AC:
12000
AN:
41474
American (AMR)
AF:
0.212
AC:
3232
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
377
AN:
3468
East Asian (EAS)
AF:
0.168
AC:
867
AN:
5174
South Asian (SAS)
AF:
0.319
AC:
1540
AN:
4822
European-Finnish (FIN)
AF:
0.110
AC:
1162
AN:
10584
Middle Eastern (MID)
AF:
0.282
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
0.0839
AC:
5709
AN:
68016
Other (OTH)
AF:
0.168
AC:
355
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1041
2083
3124
4166
5207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
272
544
816
1088
1360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.118
Hom.:
402
Bravo
AF:
0.175
Asia WGS
AF:
0.254
AC:
884
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.32
DANN
Benign
0.39
PhyloP100
-0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11888095; hg19: chr2-136422784; API